All Stories
Follow
Subscribe to aap Implantate AG

aap Implantate AG

ots Ad hoc-Service: aap Implantate AG <DE0005066609> Acquiring Coripharm, Mebio and Corimed plus 49% stake in Osartis, aap Implantate AG expands into promising orthobiology sector

Berlin (ots Ad hoc-Service) -

Ad hoc-announcement edited and sent by DGAP. The sender is solely
responsible for the contents of this announcement.
   Acquiring Coripharm, Mebio and Corimed plus 49% stake in Osartis,
aap Implantate AG expands into promising orthobiology sector
aap Implantate AG, one of the leading German companies in the
biomedical implant sector, is expanding the promising biological
implant business field. It has acquired 100% of Coripharm, Mebio and
Corimed, based in Dieburg, Germany, and a 49% stake in Obernburg-
based, Germany, Osartis. The four companies are involved in
biological bone substitute, osteosynthesis, endoprosthetics and local
wound-healing.
For aap, these acquisitions and holdings in Germany represent a
crucial step toward becoming an all-round supplier in the
orthopaedics market. Its core business fields have hitherto been
osteosynthesis (bone fracture healing), and endoprosthetics, (joint
replacements). The acquisition now takes aap forward into a third
sector: orthobiology (biological implants). Alongside additional
innovative products, aap has now acquired, via these acquisitions and
holdings, a research team with long years of experience, a total of
17 patents in the above-mentioned business fields and an
international network of recognized research scientists and
practical, working physicians.
The six companies in which aap is now a shareholder were
previously separate and independent companies both legally and
organisationally. Between them, with a staff of about 30, they
achieved a turnover of roughly DM 8.3 million in 1999. They are, in
detail:
  • Coripharm Medizinprodukte GmbH & Co. KG (research and product development for endoprosthetics, bone substitutes and local wound healing)
  • Coripharm Medizinprodukte-Verwaltungs GmbH (partnership company) - Mebio Medizintechnische Biomaterialien GmbH (sales and administration for the above-mentioned products) - Corimed Kundenorientierte Medizinprodukte GmbH (parent company of Mebio Medizintechnische Biomaterialien GmbH) - Osartis GmbH & Co. KG (developing and manufacturing bone substitute materials)
  • Osartis Verwaltungs-GmbH (partnership company)
aap Implantate AG expects, in addition to moving forward into
orthobiology, to gain considerable growth potential from widening its
product range and integrating the sales structures and the
manufacturing capacities.
If you have any queries, please contact:
aap Implantate AG
Bruke Seyoum Alemu Gabriele Voßkühler Member of the Board of
Management Investor Relations Finance and Information Technology
Lorenzweg 5 Lorenzweg 5
12099 Berlin 12099 Berlin
Tel: +49 (0)30 / 750 19-170 Tel.: +49 (0)30 / 750 19-133 Fax: +49
(0)30 / 750 19-111 Tel.: +49 (0)30 / 750 19-111
End
Internet: http://recherche.newsaktuell.de

Original content of: aap Implantate AG, transmitted by news aktuell

More stories: aap Implantate AG
More stories: aap Implantate AG